Chondroitin Sulfate Market to grow at a 3.4% CAGR - MDC Research
Market Data Centre
Market Data Centre

Chondroitin Sulfate Market by Application (Dietary Supplements, Veterinary, Pharmaceutical and Cosmetics), and Source (Porcine and Bovine) - Global Analysis & Forecast 2022-2030

Pune, April 21, 2022 (GLOBE NEWSWIRE) -- The global chondroitin sulfate market is driven rising demand for pet foods and rising preference for nutraceutical and pharmaceutical products globally. Moreover, rising incidences of osteoarthritis has been pivotal in contributing to the extensive growth of the global chondroitin sulfate market. Osteoarthritis is considered to be the most common form of joint disorders in the United States, with an estimated 30.8 million adults suffering from the same. However, adverse reactions arising from long-term utilization of this products coupled with religious & social barriers among several countries are likely to restrain the market to a certain extent.

Global Chondroitin Sulfate Market is estimated to be over USD 2.17 Billion by 2030. It is anticipated to grow at a 3.4% CAGR from 2022 to 2030.


Chondroitin Sulfate Market by Region

The global chondroitin sulfate market can be segmented into North America, Asia Pacific, Europe and Rest of World (ROW). North America will continue to dominate the global chondroitin sulfate market in the forecast period owing to factors such as high prevalence of osteoarthritis, and availability of wide range of chondroitin sulfate products among others. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, Korea, Japan and India. Factors such as rising customer awareness regarding dietary supplements, and high prevalence of bone disorders have been crucial in contributing to the growth of this segment.



Download Sample PDF
https://www.marketdatacentre.com/samplepdf/97


  1. COMPANY PROFILES (Business Overview, Products Offered, Financial Performance, Recent Developments)*

    1. Bioiberica S.A.U.

    2. Sigma-Aldrich (Merck KGaA)

    3. Sioux Pharm, Inc.

    4. Jiaxing Hengjie Biopharmaceutical Co., Ltd.

    5. SEIKAGAKU CORPORATION

    6. ZPD (Zeria Group)

    7. Synutra, Inc.

    8. Summit Nutritionals International

    9. PACIFIC RAINBOW INTERNATIONAL, INC.

    10. TSI Group Ltd

Vendor Assessment

Vendor assessment includes a deep analysis of how vendors are addressing the demand in the Chondroitin Sulfate Market. The MDC Competetive Scape model was used to assess qualitative and quantitative insights in this assessment. MDC's Competitive Scape is a structured method for identifying key players and outlining their strengths, relevant characteristics, and outreach strategy. MDC's Competitive Scape allows organizations to analyze the environmental factors that influence their business, set goals, and identify new marketing strategies. MDC Research analysts conduct a thorough investigation of vendors' solutions, services, programs, marketing, organization size, geographic focus, type of organization and strategies.